logo
kWh Analytics and Nextracker Collaborate to Cut Municipal Solar Insurance Deductible by 50 Percent Through Innovative Hail Stow Technology

kWh Analytics and Nextracker Collaborate to Cut Municipal Solar Insurance Deductible by 50 Percent Through Innovative Hail Stow Technology

Business Wire23-04-2025

SAN FRANCISCO--(BUSINESS WIRE)--kWh Analytics, the market leader in Climate Insurance, today announced a successful collaboration with Nextracker, a global leader in advanced solar energy solutions, that resulted in a 50 percent reduction in severe convective storm deductible for a solar project in Arkansas. This partnership demonstrates how strategic technology implementation can significantly improve insurance terms while enhancing risk mitigation for renewable energy assets.
This partnership demonstrates how strategic technology implementation can significantly improve insurance terms while enhancing risk mitigation for renewable energy assets.
The collaboration was initiated when traditional carriers became unwilling to cover a municipal solar developer's hail risk, a growing challenge for solar assets in severe weather regions. kWh Analytics, recognizing that the project employed Nextracker's solar tracking systems, developed an innovative insurance structure with comprehensive hail limits with low deductibles contingent on the implementation of Nextracker NX Horizon Hail Pro™ automated stow technology.
'This collaboration with Nextracker exemplifies how data-driven underwriting can incentivize resilience measures and benefit all stakeholders,' said Jason Kaminsky, CEO of kWh Analytics. 'By quantifying the risk reduction from advanced technologies like automated hail stow, we're able to offer significantly improved insurance terms.'
The NX Horizon™ tracker system features core technology that enables rapid stowing without relying on grid power. The Nextracker asset management team collaborated with the municipal utility to upgrade existing tracker systems to include Hail Pro control system hardware and firmware, unlocking automatic stow capability. These enhancements included integrating DTN hail forecasting service and Nextracker's tailored hail stow thresholds, which trigger automatic stowing based on hail size, proximity to the site, and likelihood of impact.
'As extreme weather events become more frequent, having the ability to actively mitigate hail risk is becoming essential for solar asset owners and insurers,' said Andrew Griffiths, vice president asset management, Nextracker. 'Our Hail Pro technology is delivering measurable value by keeping critical infrastructure operating in the field, and in this case, contributing to lower insurance deductibles. This collaboration proves that smarter tracker design and advanced software can strengthen asset resilience and improve project economics.'
For the developer, the benefits extended beyond insurance savings to operational improvements and peace of mind. 'This is so much easier and lets us sleep better at night and focus on preserving utility services for our community members,' said the municipal utility operations manager.
This collaboration exemplifies how partnerships across the renewable energy industry can deliver tangible benefits for all stakeholders. When technology providers, insurers, and asset owners work together, they create innovative solutions that can reduce risk, lower costs, and enhance project reliability.
You can learn more about the insurance deductible benefits resulting from this collaboration in kWh Analytics' case study.
ABOUT kWh Analytics
kWh Analytics, a leading Climate Insurance provider, underwrites property insurance and revenue firming products for renewable energy assets. Our proprietary database of 300,000+ zero-carbon projects and $100B in loss data fuels advanced modeling and insights, enabling precise underwriting decisions. This data-driven approach incorporates resiliency measures in risk evaluation, promoting sustainable practices in the renewable energy sector.
Trusted by 5 of the top 10 global (re)insurance carriers, we've insured over $40 billion in assets to date. Our tailored solutions further our mission of providing best-in-class Insurance for our Climate. Recognized by InsuranceERM Climate and Sustainability Awards, kWh Analytics continues to pioneer in the renewable energy insurance sector.
Learn more at https://www.kwhanalytics.com/, or LinkedIn

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

VeriSilicon Expands DSP Portfolio with Silicon-Proven ZSP5000 Vision Core Series for Edge Intelligence
VeriSilicon Expands DSP Portfolio with Silicon-Proven ZSP5000 Vision Core Series for Edge Intelligence

Business Wire

timean hour ago

  • Business Wire

VeriSilicon Expands DSP Portfolio with Silicon-Proven ZSP5000 Vision Core Series for Edge Intelligence

SHANGHAI--(BUSINESS WIRE)--VeriSilicon ( today released the ZSP5000 Digital Signal Processing (DSP) series IPs, which are based on its fifth-generation silicon-proven DSP architecture. This product line adopts a highly scalable and energy-efficient design, and has been deeply optimized for compute-intensive workloads such as computer vision and embedded AI. Combined with the configurable nature of the architecture, this series of IP can provide excellent solutions with both energy and computing efficiency for various edge devices. With the growing adoption of OpenCV and the increasing demand for computer vision workloads alongside NPUs in edge intelligence computing, we are introducing the ZSP5000—our next-generation DSP IP series. Share The ZSP5000 series IPs include ZSP5000, ZSP5000UL, ZSP5000L, and ZSP5000H, delivering scalable vector processing performance ranging from 32 to 256 8-bit Multiply-Accumulate (MAC) operations per cycle. For even higher performance, VeriSilicon's multi-core ZSP5400H can combine multiple ZSP5000H cores in a multi-cluster architecture to further scale computing capability. The ZSP5000 series features a rich and intuitive instruction set optimized for ease of programming and efficient performance tuning, while its dedicated instructions accelerate common imaging and signal processing tasks such as vector-scalar arithmetic, horizontal reductions, permutations, shifts, table lookups, clamping, and averaging. It integrates the ZTurbo coprocessor interface, allowing customers to easily add custom instructions and hardware accelerators within the same pipeline, and is compatible with the OpenCV Application Programming Interface (API), ensuring seamless integration with the mainstream computer vision frameworks. Additionally, the ZSP5000 series is equipped with a full-featured memory subsystem, a multi-channel 3D DMA engine, and a scalable multicore configuration, supporting flexible deployment for a broad spectrum of applications. The ZSP5000 series IPs are backward compatible with VeriSilicon's scalar ZSPNano series, efficiently handling mixed MCU and DSP workloads. VeriSilicon also offers comprehensive ZView development tools, including an Eclipse-based Integrated Development Environment (IDE), cycle-accurate simulator, optimizing compiler, debugger, and profiling tools, streamlining software development and system integration. 'With the growing adoption of OpenCV and the increasing demand for computer vision workloads alongside NPUs in edge intelligence computing, we are introducing the ZSP5000—our next-generation DSP IP series. It supports the industry-standard OpenCV API, enables streamlined interfacing with NPUs via our FLEXA interface, and integrates built-in audio processing capabilities for multi-modal applications,' said Weijin Dai, Chief Strategy Officer, Executive Vice President, and General Manager of the IP Division at VeriSilicon. 'Energy efficiency is key at the edge, and the ZSP5000 series IPs feature an optimized memory access architecture to minimize processor power consumption. It also features ZTurbo, a custom instruction extension mechanism designed for targeted applications, which enables further power and performance optimization through seamless integration of hardware accelerators. Our leading customers are already leveraging these capabilities to achieve significant advancements in power and performance.' VeriSilicon is committed to providing customers with platform-based, all-around, one-stop custom silicon services and semiconductor IP licensing services leveraging its in-house semiconductor IP. For more information, please visit:

AGC Biologics Expands Cell Therapy Development Operations to Asia to Serve Growing Market Need
AGC Biologics Expands Cell Therapy Development Operations to Asia to Serve Growing Market Need

Business Wire

timean hour ago

  • Business Wire

AGC Biologics Expands Cell Therapy Development Operations to Asia to Serve Growing Market Need

TOKYO--(BUSINESS WIRE)--AGC Biologics, your friendly CDMO expert, will commence cell therapy process development and clinical manufacturing services on July 1, 2025, at AGC Inc.'s Yokohama Technical Center, marking the latest step in the global expansion of the company's Global Cell and Gene Technologies Division. The improved geographical footprint allows AGC Biologics to better serve customers requiring autologous and allogeneic products across all markets, with cell therapy manufacturing now available in three continents (Milan, Italy – Longmont, Colorado, U.S. – Yokohama, Japan). This new site precedes the opening of a new AGC Biologics Yokohama manufacturing facility on schedule to be operational in 2027 with pre-clinical through commercial services for mammalian-based protein biologics, cell therapies, and messenger RNA. The Yokohama location will provide process transfer and manufacturing services for pre-clinical and clinical trials to serve an expanding global cell therapy market. Its core technologies include induced pluripotent stem cells, mesenchymal stem cells, hematopoietic stem cells, and CAR-T cell therapies. AGC Biologics Cell and Gene Technology Center of Excellence in Milan, with its nine product approvals by the EMA and FDA, hundreds of batches manufactured, and 30-year track record, will support and enable the successful ramp up of operation in the new Yokohama site. 'In a cell and gene therapy market of high volatility and witnessing consolidation of CDMOs, AGC Biologics is among the few experiencing significant growth and success. We are now building on this success to complete the vision of having a truly global offering,' said Luca Alberici, Executive Vice President of Global Cell and Gene Technologies at AGC Biologics. 'Now Asian developers can benefit from having a local supply within one of the best global infrastructures on the market for cell therapy. Moreover, customers can continue to leverage the offering of viral vector central supply in our Milan facility, which supplies around a third of the ex vivo gene therapy product approved for commercialization. AGC Biologics, through its proprietary ProntoLVV and BravoAAV platforms, aims to offer viral vectors at a sustainable cost for its clients targeting less than 1,000€ per CAR-T patient.' 'Our team of friendly experts in Milan have a strong reputation for collaboration and working side-by-side with customers to achieve clinical, late-phase, and commercial successes,' said Jun Takami, Senior Vice President and General Manager, Japan Region and Yokohama Facility. 'As part of this next major phase for cell therapy in the region, our Yokohama team is ready to support partners in accelerating drug development timelines while maintaining the highest quality standards in the industry." AGC Biologics is a part of AGC Inc.'s Life Science Company. The Life Science company operates over 10 facilities worldwide focused on biopharmaceuticals, advanced therapies, small molecule active pharmaceutical ingredients, and agrochemicals. The AGC Inc. Yokohama Technical Center, built in 2020, is dedicated to advancing AGC Inc.'s research and development capabilities in materials science, chemical processes, and biotechnology. Please visit to learn more about AGC Biologics' global network of services for protein biologics and cell and gene therapies. About AGC Biologics AGC Biologics is a leading global biopharmaceutical Contract Development and Manufacturing Organization (CDMO) with a strong commitment to delivering the highest standard of service as we work side-by-side with our clients and partners, to provide friendly and expert services. We provide world-class development and manufacturing of mammalian and microbial-based therapeutic proteins, plasmid DNA (pDNA), messenger RNA (mRNA), viral vectors, and genetically engineered cells. Our global network spans the U.S., Europe, and Asia, with locations in Seattle, Washington; Boulder and Longmont, Colorado; Copenhagen, Denmark; Heidelberg, Germany; Milan, Italy; and Chiba and Yokohama, Japan. We currently employ more than 2,600 Team Members worldwide.

Delek Logistics Partners, LP Announces Pricing of Upsized Offering of $700 Million of Senior Notes
Delek Logistics Partners, LP Announces Pricing of Upsized Offering of $700 Million of Senior Notes

Business Wire

time2 hours ago

  • Business Wire

Delek Logistics Partners, LP Announces Pricing of Upsized Offering of $700 Million of Senior Notes

BRENTWOOD, Tenn.--(BUSINESS WIRE)--Delek Logistics Partners, LP (NYSE: DKL) ('Delek Logistics') announced today that it, along with Delek Logistics Finance Corp., a subsidiary of Delek Logistics, priced an upsized offering of $700 million in aggregate principal amount of 7.375% senior notes due 2033 (the 'Notes') at par. The offering is expected to close June 30, 2025, subject to satisfaction of customary closing conditions. Delek Logistics intends to use the net proceeds from the offering to repay a portion of the outstanding borrowings under its revolving credit facility. The Notes are being offered only to persons reasonably believed to be qualified institutional buyers in an offering exempt from registration in reliance on Rule 144A under the Securities Act of 1933, as amended (the 'Securities Act'), and to non-U.S. persons outside the United States in reliance on Regulation S under the Securities Act. The Notes and related guarantees have not been registered under the Securities Act or any state securities laws and may not be offered or sold in the United States without registration or an applicable exemption from the registration requirements of the Securities Act or any applicable state securities laws. This press release is being issued pursuant to Rule 135c under the Securities Act, and is neither an offer to sell nor a solicitation of an offer to buy the Notes or any other securities and shall not constitute an offer to sell or a solicitation of an offer to buy, or a sale of, the Notes or any other securities in any jurisdiction in which such offer, solicitation or sale is unlawful. About Delek Logistics Partners, LP Delek Logistics is a midstream energy master limited partnership headquartered in Brentwood, Tennessee. Through its owned assets and joint ventures located primarily in and around the Permian Basin, the Delaware Basin and other select areas in the Gulf Coast region, Delek Logistics provides gathering, pipeline and other transportation services primarily for crude oil and natural gas customers, storage, wholesale marketing and terminalling services primarily for intermediate and refined product customers, and water disposal and recycling services. Delek US Holdings, Inc. (NYSE: DK) owns the general partner interest as well as a majority limited partner interest in Delek Logistics, and is also a significant customer. Forward-Looking Statements This press release contains 'forward-looking statements' within the meaning of Section 27A of the Securities Act and Section 21E of the Securities Exchange Act of 1934, as amended, including statements regarding the closing of the offering and the anticipated use of the net proceeds therefrom. These statements may contain words such as 'possible,' 'believe,' 'should,' 'could,' 'would,' 'predict,' 'plan,' 'estimate,' 'intend,' 'may,' 'anticipate,' 'will,' 'if,' 'expect' or similar expressions, as well as statements in the future tense, are made as of the date they were first issued and are based on current expectations, estimates, forecasts and projections as well as the beliefs and assumptions of management. Forward-looking statements are subject to a number of risks and uncertainties, many of which involve factors or circumstances that are beyond Delek Logistics' control. Delek Logistics' actual results could differ materially from those stated or implied in forward-looking statements due to a number of factors, including, but not limited to, market risks and uncertainties, including those which might affect the offering. These and other potential risks and uncertainties that could cause actual results to differ from the results predicted are more fully detailed in Delek Logistics' filings and reports with the U.S. Securities and Exchange Commission ('SEC'), including the Annual Report on Form 10-K for the year ended December 31, 2024, the Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025 and other reports and filings with the SEC.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store